Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Roser

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 22, 2022
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cellsLuise A Roser, Pelin Erkoc, Rebecca Ingelfinger, et al.
Journal of Medicinal Chemistry|May 23, 1998
Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malariaJ H McKie, K T Douglas, C Chan, et al.
Journal of Immunotoxicology|April 5, 2024
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP conceptLuise A Roser, Christina Sakellariou, Malin Lindstedt, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound SilvestrolSusanne Schiffmann, Sandra Gunne, Thomas Ulshöfer, et al.
Journal of Immunotoxicology|December 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathwaysAlexander Mazein, Muhammad Shoaib, Miriam Alb, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 22, 2022
Lecanoric acid mediates anti-proliferative effects by an M phase arrest in colon cancer cellsLuise A Roser, Pelin Erkoc, Rebecca Ingelfinger, et al.
Journal of Medicinal Chemistry|May 23, 1998
Rational drug design approach for overcoming drug resistance: application to pyrimethamine resistance in malariaJ H McKie, K T Douglas, C Chan, et al.
Journal of Immunotoxicology|April 5, 2024
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP conceptLuise A Roser, Christina Sakellariou, Malin Lindstedt, et al.
Pharmaceuticals (Basel, Switzerland)|September 23, 2022
In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound SilvestrolSusanne Schiffmann, Sandra Gunne, Thomas Ulshöfer, et al.
Journal of Immunotoxicology|December 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathwaysAlexander Mazein, Muhammad Shoaib, Miriam Alb, et al.
Pageof 2